Functional Interaction of a β-Adrenergic Agonist and Cyclic GMP Phosphodiesterase Inhibitor in Control and Hypertrophic Cardiomyocytes

Publisher： Karger

E-ISSN： 1423-0313|76|2|53-60

ISSN： 0031-7012

Source： Pharmacology, Vol.76, Iss.2, 2006-01, pp. : 53-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SERCA Inhibition Limits the Functional Effects of Cyclic GMP in Both Control and Hypertrophic Cardiac Myocytes

By  

Pharmacology, Vol. 83, Iss. 4, 2009-03 ,pp. : 223-230

Karger

Access to resources Recommend Favorite

Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?

By Vamecq Joseph   Mention-Mulliez Karine   Leclerc Francis   Dobbelaere Dries  

Pharmaceuticals, Vol. 8, Iss. 4, 2015-09 ,pp. : 664-674

MDPI

Access to resources Recommend Favorite

Decreasing Cyclic GMP Exerts Similar Positive Functional Effects on Cardiac Myocytes Regardless of Initial Level

By  

Pharmacology, Vol. 61, Iss. 1, 2000-07 ,pp. : 51-56

Karger

Access to resources Recommend Favorite

Dexamethasone-Induced Increase in Lymphocyte β-Adrenergic Receptor Density and cAMP Formation in vivo

By  

Pharmacology, Vol. 67, Iss. 1, 2002-12 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure

By Crocini Claudia   Coppini Raffaele   Ferrantini Cecilia   Yan Ping   Loew Leslie M.   Poggesi Corrado   Cerbai Elisabetta   Pavone Francesco S.   Sacconi Leonardo  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1471-1471

MDPI

Access to resources Recommend Favorite